30/04/2020

CRISPR and Coronavirus

A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
09/03/2020

EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas.
30/11/2019

EuropaBio position on Germline Genome Editing

EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet.
25/06/2019

Achieving the Potential of Genome Editing: the Perspective of the European Biotech Industry

EuropaBio, the voice of the biotech industry, has developed this paper to bring the latest views from the developers and users of genome editing tools and applications.
09/05/2019

Open Letter to Member States on the EU Court Ruling on Mutagenesis

Open Letter to Member States on the EU Court Ruling on Mutagenesis.
29/11/2018

Statement: As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products

As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products.
27/09/2017

Joint Press Release on ATMPs and GMOs in Europe

Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
Become a member